Literature DB >> 18251361

Risks of third-trimester amniocentesis.

Ivica Zalud1, Sapna Janas.   

Abstract

OBJECTIVE: To establish the risk of immediate complications from third-trimester amniocentesis. STUDY
DESIGN: The entry criterion was amniocentesis done in the third trimester (28 or more weeks of gestation). The primary study outcome was any complication within 24 hours after the procedure. The secondary outcome was mode of delivery and pregnancy outcome.
RESULTS: One hundred eleven patients were enrolled in this study with a known postprocedure course and pregnancy outcome. The average patient age was 29.8 years, average gravidity 2.9, average gestational age 36 weeks, average amount of amniotic fluid withdrawn 12.9 mL and average number of attempts to perform amniocentesis 1.03. The most common indication for the procedure was fetal lung maturity study and workup for chorioamnionitis. The list of complications observed within 24 hours included: regular contractions (2 patients, or 1.8%), ruptured membranes (1 patient, or 0.9%) and minimal vaginal bleeding (1 patient, or 0.9%). The overall complication rate was 3.6%. There was no perinatal or maternal morbidity directly linked to the procedure. No patients with complications needed urgent delivery.
CONCLUSION: Third-trimester amniocentesis carried a complication rate of 3.6%. All complications were self-limited.

Entities:  

Mesh:

Year:  2008        PMID: 18251361

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  6 in total

1.  Amniocentesis for fetal lung maturity: will it become obsolete?

Authors:  Stephen Varner; Craig Sherman; David Lewis; Sheri Owens; Frankie Bodie; C Eric McCathran; Nicolette Holliday
Journal:  Rev Obstet Gynecol       Date:  2013

2.  Prediction of neonatal respiratory morbidity by quantitative ultrasound lung texture analysis: a multicenter study.

Authors:  Montse Palacio; Elisenda Bonet-Carne; Teresa Cobo; Alvaro Perez-Moreno; Joan Sabrià; Jute Richter; Marian Kacerovsky; Bo Jacobsson; Raúl A García-Posada; Fernando Bugatto; Ramon Santisteve; Àngels Vives; Mauro Parra-Cordero; Edgar Hernandez-Andrade; José Luis Bartha; Pilar Carretero-Lucena; Kai Lit Tan; Rogelio Cruz-Martínez; Minke Burke; Suseela Vavilala; Igor Iruretagoyena; Juan Luis Delgado; Mauro Schenone; Josep Vilanova; Francesc Botet; George S H Yeo; Jon Hyett; Jan Deprest; Roberto Romero; Eduard Gratacos
Journal:  Am J Obstet Gynecol       Date:  2017-03-23       Impact factor: 8.661

Review 3.  Update on inherited disorders of haemostasis and pregnancy.

Authors:  Orly Lavee; Giselle Kidson-Gerber
Journal:  Obstet Med       Date:  2016-01-20

4.  Comparison between Cervical Ureaplasma spp. Colonization and the Intensity of Inflammatory Mediators in the Amniotic Fluid Retrieved during Cesarean Delivery in Preterm Birth.

Authors:  Jingon Bae; Shin Kim; Ilseon Hwang; Jaehyun Park
Journal:  Int J Environ Res Public Health       Date:  2021-12-23       Impact factor: 3.390

5.  The association between amniotic fluid-derived inflammatory mediators and the risk of retinopathy of prematurity.

Authors:  Ji Hye Jang; Jae-Gon Kim; Yu Hyun Lee; Jin Gon Bae; Jae Hyun Park
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

6.  Prolidase, matrix metalloproteinases 1 and 13 activity, oxidative-antioxidative status as a marker of preterm premature rupture of membranes and chorioamnionitis in maternal vaginal washing fluids.

Authors:  Hatice Ender Soydinc; Muhammet Erdal Sak; Osman Evliyaoglu; Mehmet Sıddık Evsen; Abdulkadir Turgut; Ali Özler; İsmail Yıldız; Talip Gul
Journal:  Int J Med Sci       Date:  2013-08-15       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.